An Updated Snapshot of Recent Advances in Transcriptomics and Genomics of Phytomedicinals

Medicinal plants have been of great importance to human health care since the advent of medicine. A huge array of molecules has been obtained from these phytopharmaceutical-yielding species that have influenced human lives since the beginning of plant-based life-saving medicines. Some of these molecules have taken the form of taxol, aspirin, and artemisinin. With the flourishing era of highthroughput next generation sequencing technologies, a hot pursuit for sequencing the genomes and transcriptomes of these life-saving plants is underway. Although few genomes have been sequenced or are currently being addressed, the number of transcriptomes sequenced has sky-rocketed in the last couple of years and continues to surge forward with immense pace, covering all important genera of medicinal plants. I have attempted to provide the current status, progress, opportunities, and challenges of these sequencing endeavors in this comprehensive and updated review. It is my hope that this information will provide both specialists and non-specialists with the current trends and future directions of this interesting category of plants.